MRC Scientists Find Better Way to Predict the Outcome of Breast Cancer Following SurgeryDecember 03, 2003MRC Scientists have found a better way to predict the outcome of breast cancer following surgery which might lead to the improved management of the disease. The discovery, published in the Journal of Clinical Oncology, complements the methods doctors currently use to predict the outcome of breast cancer following surgery in order to choose the best course of treatment for individual patients. The research team, led by Dr Nicholas Coleman of the MRC Cancer Cell Unit, examined breast cancer tissue removed in surgery and found that a protein called Mcm-2 gives a more precise indication of how quickly tumour cells in breast cancer grow. This allows doctors to establish the status of the disease more accurately, which in turn helps them make better predictions of overall survival and to determine the chances of a tumour recurring after treatment or of the cancer spreading to other organs. Dr Coleman said: "This is good news for women with breast cancer as an accurate assessment of the outcome following surgery is key to choosing how much further therapy is needed for an individual patient. It is important that patients receive neither too little nor too much additional treatment for their tumours. Cancer Research UK (CRUK) also funded the research. Professor Robert Souhami, CRUK's Director of Clinical and External Affairs, said: Breast cancer accounts for almost one in three of all cancers in women. Each year there are nearly 41,000 new cases in the UK. | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||